Art in Improving Outcomes in Participants Undergo Surgery
NCT ID: NCT03688945
Last Updated: 2022-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
80 participants
INTERVENTIONAL
2017-08-07
2019-11-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Light Therapy on Post-Surgical Pain
NCT05853731
Determining the Effectiveness of a New Phototherapy Treatment for the Knee Osteoarthritis
NCT04234685
Green Light for Post-Operative Wellness
NCT07218289
Telehealth Exercise and Mindfulness for Pain in Osteoarthritis - Stage 1B
NCT06684587
Can Computer-based Telephone Counseling Improve Long-term Adherence to Strength Training in Elders With Knee OA?
NCT01394874
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Investigate through evidence-based randomized controlled trial the effect of exposure to art during the perioperative period on the outcome of surgical outcomes II. Assess patient response to artwork and investigate the correlation of patient response with the clinical outcomes of the patients.
III. Measure cognitive changes that may occur for patients based on art exposure.
OUTLINE: Participants are randomized into 1 of 2 arms.
ARM I: Participants attend at least 2 sessions of viewing art pieces over 15 minutes every day for 2 years.
ARM II: Participants receive standard of care for 2 years.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I (art sessions)
Participants attend at least 1 session of viewing art pieces over 15 minutes every day for 2 years.
Art Therapy
Attend art viewing sessions
Questionnaire Administration
Ancillary studies
Arm II (standard of care)
Participants receive standard of care for 2 years.
Best Practice
Receive standard of care
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Art Therapy
Attend art viewing sessions
Best Practice
Receive standard of care
Questionnaire Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All races and ethnic groups are eligible for this study
Exclusion Criteria
* Adult unable to consent, individuals who are not yet adults, pregnant women or prisoners
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Roswell Park Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Khurshid Guru
Role: PRINCIPAL_INVESTIGATOR
Roswell Park Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Roswell Park Cancer Institute
Buffalo, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2018-00457
Identifier Type: REGISTRY
Identifier Source: secondary_id
I 43217
Identifier Type: OTHER
Identifier Source: secondary_id
I 43217
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.